Viewing nowAtorvan 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 201306231 · Approved 2013.03.18 · Insurance code 648103260
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of myocardial infarction, stroke, the need for vascular surgery, angina, and hospitalization for congestive heart failure in patients with various risk factors for cardiovascular diseases. It also lowers total cholesterol and LDL-cholesterol in hyperlipidemia patients while increasing HDL-cholesterol, thereby improving blood lipid levels. It is safe to administer to pediatric patients with heterozygous familial hypercholesterolemia who have a family history or other risk factors to control blood cholesterol levels. This drug functions as an effective dietary supplement for the prevention and treatment of cardiovascular diseases.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Ages 10 ~ 17: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this medication in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may pose a risk of muscle-related issues, so if severe muscle pain or weakness occurs, usage should be immediately discontinued and a doctor should be informed. This medication should not be used in patients with certain liver diseases, muscle diseases, pregnant or potentially pregnant women, children under 10 years of age, and those taking specific medications. Patients with a history of alcoholism or liver disease, diminished kidney function, hypothyroidism, and those at high risk of myopathy should undergo careful examination before using this medication. Various side effects such as liver function abnormalities, muscle pain, allergic reactions, and gastrointestinal symptoms may occur during the use of this medication, so any symptoms should be reported to healthcare professionals. Particularly, if muscle pain is accompanied by fatigue, fever, or weakness, there may be a risk of muscle damage; consequently, immediate testing is required, and if blood tests reveal elevated muscle enzyme levels, the medication should be discontinued. Since this medication is metabolized in the liver, patients with impaired liver function may require dose adjustments, and if symptoms of hepatitis or liver function abnormalities occur, administration should be stopped immediately. Women planning for pregnancy or who are potentially pregnant must use contraception during treatment, and the medication should be discontinued if pregnancy is confirmed. This medication is not recommended for breastfeeding women, and those who are nursing should avoid taking it. There are numerous drug interactions associated with this medication, and depending on the concomitant medications taken, the risk of myopathy or liver function abnormalities may increase, so all medications currently in use should be disclosed to healthcare professionals. In the case of overdose, there is no specific antidote; treatment should be symptomatic, and liver function and muscle enzyme levels should be checked regularly. This medication should be kept out of reach of children and stored in its original container for safety. Elderly patients or those with kidney disorders are at higher risk for myopathy, so careful monitoring is necessary when using this medication.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This helps maintain the medication's efficacy and safety for a longer duration.
White oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.